COST NO FEENO SET ASIDE USED.

COLORADO STATE UNIVERSITY - COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.

PIID: 75N93020C00053Solicitation ID: HHS-NIH-NIAID-BAA2020-1
Signed Date: Jan 6, 2026Effective Date: Sep 1, 2020End Date: Closes in 689 days
Award $
$6.3M
Vendor
COLORADO STATE UNIVERSITY
NAICS
541715
Signed Date
Jan 6, 2026

Key Details

Dollars Obligated
$6.3M
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AJ12 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
23
Place of Performance
FORT COLLINS, CO, 805232002, CD-CO-02

Description

COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.

Context & Analysis

On Jan 6, 2026, Department of Health and Human Services obligated $6,280,811 to COLORADO STATE UNIVERSITY for covid-19. to develop and manufacture an inactivated virus vaccine using blood pathogen reduction technology.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 23 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in FORT COLLINS, CO. The contract is scheduled through Apr 30, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.

Contractor Information

UEI: LT9CXX8L19G1
CAGE Code: 4B575
Location: FORT COLLINS, CO
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related